<DOC>
	<DOCNO>NCT01148368</DOCNO>
	<brief_summary>The purpose study compare evaluate pharmacokinetic characteristic safety fimasartan renal impairment patient healthy volunteer .</brief_summary>
	<brief_title>A Clinical Trial Compare Evaluate Pharmacokinetic Characteristics Safety Fimasartan Renal Impairment Patients Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>&lt; Renal impairment patient &gt; age : 2065 year eGFR : &lt; 30ml/min/1.73m^2 dialysis body weight : great 55kg write informed consent &lt; Healthy volunteer &gt; age : 2065 year body weight : great 55kg write informed consent AST , ALT &gt; 1.5 time upper normal range positive drug alcohol screening</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>fimasartan</keyword>
	<keyword>renal impairment</keyword>
	<keyword>hypertension</keyword>
</DOC>